Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

21drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

TNG260

This drug is selected. Its supporting articles are shown below.

2 articles · page 1 of 1

jitc · abstract · 2025-11-04 · 12 matching annotations

98.6%

…by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated in a pha…

jitc · abstract · 2025-11-04 · 9 matching annotations

98.3%

…tial treatment strategy for patients with STK11-mutated tumors. TNG260 in combination with pembrolizumab is currently being evaluated …